<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-04-29T00:37:39Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10036978" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10036978</identifier>
        <datestamp>2023-03-24</datestamp>
        <setSpec>phenaturepg</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Clin Oral Investig</journal-id>
              <journal-id journal-id-type="iso-abbrev">Clin Oral Investig</journal-id>
              <journal-title-group>
                <journal-title>Clinical Oral Investigations</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1432-6981</issn>
              <issn pub-type="epub">1436-3771</issn>
              <publisher>
                <publisher-name>Springer Berlin Heidelberg</publisher-name>
                <publisher-loc>Berlin/Heidelberg</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10036978</article-id>
              <article-id pub-id-type="pmcid">PMC10036978</article-id>
              <article-id pub-id-type="pmc-uid">10036978</article-id>
              <article-id pub-id-type="pmid">36961592</article-id>
              <article-id pub-id-type="publisher-id">4972</article-id>
              <article-id pub-id-type="doi">10.1007/s00784-023-04972-w</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effect of clove mouthwash on the incidence of ventilator-associated pneumonia in intensive care unit patients: a comparative randomized triple-blind clinical trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jahanshir</surname>
                    <given-names>Mojgan</given-names>
                  </name>
                  <address>
                    <email>mjganjahanshir1353@gmail.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Nobahar</surname>
                    <given-names>Monir</given-names>
                  </name>
                  <address>
                    <email>Nobahar43@Semums.ac.ir</email>
                    <email>Nobahar43@yahoo.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ghorbani</surname>
                    <given-names>Raheb</given-names>
                  </name>
                  <address>
                    <email>ghorbani.raheb93@gmail.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Malek</surname>
                    <given-names>Farhad</given-names>
                  </name>
                  <address>
                    <email>farhadmalek42@yahoo.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.486769.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0384 8779</institution-id><institution>Student Research Committee, </institution><institution>Semnan University of Medical Sciences, </institution></institution-wrap>Semnan, Iran </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.486769.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0384 8779</institution-id><institution>Nursing Care Research Center, </institution><institution>Semnan University of Medical Sciences, </institution></institution-wrap>Semnan, Iran </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.486769.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0384 8779</institution-id><institution>Social Determinants of Health Research Center, </institution><institution>Semnan University of Medical Sciences, </institution></institution-wrap>Semnan, Iran </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.486769.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0384 8779</institution-id><institution>Department of Nursing, Faculty of Nursing and Midwifery, </institution><institution>Semnan University of Medical Sciences, </institution></institution-wrap>Semnan, Postal Code: 3513138111 Iran </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.486769.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0384 8779</institution-id><institution>Department of Epidemiology and Biostatistics, Faculty of Medicine, </institution><institution>Semnan University of Medical Sciences, </institution></institution-wrap>Semnan, Iran </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.486769.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0384 8779</institution-id><institution>Department of Internal Medicine, Kosar Hospital, </institution><institution>Semnan University of Medical Sciences, </institution></institution-wrap>Semnan, Iran </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>24</day>
                <month>3</month>
                <year>2023</year>
              </pub-date>
              <fpage>1</fpage>
              <lpage>12</lpage>
              <history>
                <date date-type="received">
                  <day>7</day>
                  <month>11</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>19</day>
                  <month>3</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</copyright-statement>
                <license>
                  <license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>
Objectives</title>
                  <p id="Par1">Ventilator-associated pneumonia (VAP) is one of the most common nosocomial infections in intensive care units (ICUs), and the use of mouthwash is the most widely used method to prevent its incidence. The aim of this study was to investigate effect of clove mouthwash on the incidence of VAP in the ICU.</p>
                </sec>
                <sec>
                  <title>Materials and methods</title>
                  <p id="Par2">This comparative, randomized, triple-blind, clinical trial was conducted on 168 eligible ICU patients at Kosar Hospital in Semnan, Iran, during 2021–2022, who were divided into intervention and control groups using random blocks. The intervention group received clove extract mouthwash at 6.66% concentration, and the control group received chlorhexidine 0.2% twice a day for 5 days (routine care). Data were collected using a demographic questionnaire, and disease severity was measured based on the Acute Physiology and Chronic Health Evaluation II (APACHE II) score, oral health status was examined using the Beck Oral Assessment Scale (BOAS), and VAP diagnosis was made based on the Modified Clinical Pulmonary Infection Score (MCPIS).</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Before the intervention, there was no significant difference in disease severity (<italic>p</italic> = 0.412) and oral health status (<italic>p</italic> = 0.239) between the patients in the two groups. After the intervention, 20.2% of the patients in the intervention group and 41.7% of those in the control group acquired VAP. The risk of VAP was 2.06 times higher in the control group than in the intervention group (<italic>p</italic> = 0.005, 95% CI: 1.26–3.37, RR = 2.06), but the severity of VAP did not differ significantly between the patients in the two groups (<italic>p</italic> = 0.557).</p>
                </sec>
                <sec>
                  <title>Conclusion</title>
                  <p id="Par4">The findings showed that clove mouthwash reduces the incidence of VAP significantly.</p>
                </sec>
                <sec>
                  <title>Clinical relevance</title>
                  <p id="Par5">Clove mouthwash can be used as a simple and low-cost method to prevent VAP in ICU patients.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Chlorhexidine</kwd>
                <kwd>Clinical trial</kwd>
                <kwd>Clove</kwd>
                <kwd>Intensive care unit</kwd>
                <kwd>Mouthwash</kwd>
                <kwd>Patients</kwd>
                <kwd>Ventilator-associated pneumonia</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Introduction</title>
              <p id="Par6">Respiratory infection is the most frequent nosocomial infection found in intensive care units (ICUs) [<xref ref-type="bibr" rid="CR1">1</xref>]. Most patients who are hospitalized in the ICU need mechanical ventilation (MV) due to advanced respiratory problems [<xref ref-type="bibr" rid="CR2">2</xref>]. MV is performed to maintain open airways, prevent aspiration, and increase oxygenation. These supportive interventions are essential to critical care and are regarded as the benchmarks for managing the airways and ventilation [<xref ref-type="bibr" rid="CR3">3</xref>]. One of the most common side effects of MV is ventilator-associated pneumonia (VAP), which is among the most frequently occurring nosocomial infections and accounts for 25% of ICU-acquired infections [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]<bold>.</bold></p>
              <p id="Par7">VAP is a form of hospital-associated pneumonia that occurs over 48 h after endotracheal intubation. VAP is diagnosed in 15% of ICU patients and is associated with a significant mortality rate of 20–30% [<xref ref-type="bibr" rid="CR6">6</xref>]. It has been reported that 5–40% of patients undergoing invasive MV for more than 2 days acquire VAP [<xref ref-type="bibr" rid="CR7">7</xref>]. VAP is a relatively common nosocomial infection developed in critically ill patients, with a pooled incidence ranging from 23.8% [<xref ref-type="bibr" rid="CR8">8</xref>] to 36.0% [<xref ref-type="bibr" rid="CR9">9</xref>] according to recent systematic reviews. VAP remains a major contributor to hospital-acquired infections in Asia [<xref ref-type="bibr" rid="CR10">10</xref>]. The incidence rate of VAP in MV patients is 32.9% in Iran [<xref ref-type="bibr" rid="CR11">11</xref>]<bold>.</bold></p>
              <p id="Par8">The artificial airway created to establish MV changes the mucosal defense function of the natural airway, and subsequently, bacteria enter the lower respiratory tract directly or through the gap between the wall of the tracheal tube and the airway [<xref ref-type="bibr" rid="CR12">12</xref>]. The first step in the pathogenesis of infection involves the upper respiratory tract with potentially pathogenic organisms, including <italic>Pseudomonas</italic> and <italic>Escherichia coli</italic>. The entry of these microbes through the endotracheal tube or leakage around the cuff allows them to enter the lower respiratory tract, which, along with the host’s immunodeficiency, leads to active clinical infection. The common risk of developing VAP in the first week reaches its peak due to endotracheal intubation [<xref ref-type="bibr" rid="CR6">6</xref>]. Aspiration of gastrointestinal microbes also increases the risk of VAP in MV patients [<xref ref-type="bibr" rid="CR2">2</xref>]. Endotracheal intubation, the accumulation of secretions behind the tracheal tube cuff, the mouth left open and dry mouth, impairment of the cough reflex, inability to remove secretions through the pharynx and mouth, and unsatisfactory oral care may lead to VAP [<xref ref-type="bibr" rid="CR13">13</xref>]<bold>.</bold></p>
              <p id="Par9">Since VAP increases ICU length of stay, MV duration, treatment costs, and mortality [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], it is extremely important to pay close attention to VAP prevention measures [<xref ref-type="bibr" rid="CR6">6</xref>]<bold>.</bold></p>
              <p id="Par10">A review of literature shows that unsatisfactory oral care causes mucosal dryness, decrease in salivary flow, colonization of pathogenic bacteria in the mouth and oropharynx, and acquisition of VAP [<xref ref-type="bibr" rid="CR2">2</xref>]. In ICU patients, some pathologic changes develop in the oral cavity, such as oral mucosal lesions, periodontal disease relief, dry lips and dry mucous membranes, fungus infections, and increased biofilm on the oral surface. The majority of VAP cases are caused mainly by the micro-aspiration of oropharynx colonization agents [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. MV patients become incapable of chewing and are required to keep their mouth open, which reduces saliva flow and causes dryness of the mucous membranes [<xref ref-type="bibr" rid="CR16">16</xref>]. According to Ademar Takahama et al. (2021), the development of VAP may be indicated by the presence of a coated tongue and oral bleeding during ICU admission [<xref ref-type="bibr" rid="CR17">17</xref>]. There are millions of bacteria in the mouth. Although we cannot sterilize the oral environment completely, we can minimize the presence of bacteria substantially in order to prevent dry mouth and, more importantly, the accumulation of bacteria in the mouth [<xref ref-type="bibr" rid="CR18">18</xref>]<bold>.</bold></p>
              <p id="Par11">Oral care is an essential strategy to reduce the accumulation of oropharyngeal bacteria and the presence of VAP-causing bacteria [<xref ref-type="bibr" rid="CR19">19</xref>] and is thus one of the main strategies for VAP prevention [<xref ref-type="bibr" rid="CR20">20</xref>]. The incidence of VAP in the ICU may be reduced by maintaining good oral hygiene, particularly with regard to the tongue, prior to intubation [<xref ref-type="bibr" rid="CR17">17</xref>]. In the care of the critically ill, oral health is a crucial factor. According to research findings, using mouthwash containing 3% hydrogen peroxide significantly decreases the incidence of VAP compared to using mouthwash containing 0.9% normal saline [<xref ref-type="bibr" rid="CR11">11</xref>]<bold>.</bold></p>
              <p id="Par12">Oral hygiene care using mouthwash, gel, swab, and toothbrush or a combination of them along with secretion suction may reduce the risk of VAP in patients [<xref ref-type="bibr" rid="CR2">2</xref>]<bold>.</bold> Mouthwash is a very important strategy to reduce the colonization of oropharyngeal bacteria that cause VAP [<xref ref-type="bibr" rid="CR19">19</xref>]. Nonetheless, there is still no preferred protocol for the prevention of VAP [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
              <p id="Par13">Dental and mucosal cleansing with chlorhexidine may decrease the risk of VAP [<xref ref-type="bibr" rid="CR2">2</xref>]. Chlorhexidine (CHX) is a cationic biguanide that binds to the bacterial cell walls, impairing and even perforating phospholipid membranes [<xref ref-type="bibr" rid="CR22">22</xref>]. Depending on the product’s concentration, the effect may be bacteriostatic or bactericidal [<xref ref-type="bibr" rid="CR23">23</xref>]. In patients receiving MV, using chlorhexidine mouthwash for oral hygiene reduces the risk of VAP [<xref ref-type="bibr" rid="CR2">2</xref>]. Chlorhexidine works to reduce bacterial colonization in the oral cavity [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. The effectiveness of any mouthwash is restricted by the biofilm that exists on the surface of the teeth [<xref ref-type="bibr" rid="CR2">2</xref>]. Prior mechanical disruption of dental biofilms through toothbrushing improves the effect of chlorhexidine and prevents VAP [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Chlorhexidine has lipophilic groups that can bind to bacterial cell walls and change their osmotic balance [<xref ref-type="bibr" rid="CR22">22</xref>]. This effect inhibits bacterial growth and can even prevent death, and its mechanism of action depends on the concentration of the substance [<xref ref-type="bibr" rid="CR23">23</xref>]. Chlorhexidine mouthwash or gel decreases the incidence of VAP compared to placebo or routine care from 26 to about 18% (RR: 0.67, 95% confidence intervals (CI): 0.47 to 0.97; <italic>p</italic> = 0.03; <italic>I</italic><sup>2</sup> = 66%) [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
              <p id="Par14">The clinical use of chlorhexidine gluconate dates back to the 1950s. As an antiseptic mouthwash, chlorhexidine has antimicrobial effects on the bacteria, fungi, and viruses responsible for a variety of oral diseases. All the anti-bacterial effects of chlorhexidine in vitro are attributed to altered cell membrane permeability [<xref ref-type="bibr" rid="CR26">26</xref>]. Chlorhexidine has a bacteriostatic effect at low concentrations (0.02–0.06%) and causes the displacement of Ca2 + and Mg2 + and loss of K + from the cell wall [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Chlorhexidine has a bactericidal effect (cell lysis and death) at high concentrations (&gt; 0.1%) by causing leakage of all the major intracellular components out of the cell [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p>
              <p id="Par15">Mouthwashes containing chlorhexidine are considered the gold standard [<xref ref-type="bibr" rid="CR20">20</xref>]. Research findings have shown that chlorhexidine changes the nitrate-reducing bacteria in the body. Chlorhexidine seems to change the pH and lactate, nitrate, and nitrite concentrations in saliva, and chlorhexidine-containing mouthwashes may therefore lead to increased acidity and decreased nitrite concentration in the saliva by causing a major change in the salivary microbiome [<xref ref-type="bibr" rid="CR28">28</xref>]<bold>.</bold> Chlorhexidine is a guanidine-based disinfectant that affects a wide variety of bacteria, fungi, and some viruses [<xref ref-type="bibr" rid="CR29">29</xref>], but there is some controversy on its use [<xref ref-type="bibr" rid="CR30">30</xref>]. Nevertheless, chlorhexidine has numerous side effects too [<xref ref-type="bibr" rid="CR20">20</xref>]<bold>,</bold> including parotid gland swelling, oral soft tissue pigmentation, allergic reactions, taste change, burning sensation, oral mucosa ulcers, transient anesthesia, and paresthesia. In addition, chlorhexidine can cause severe adverse effects in hypertensive patients by changing the oral microbiome and consequently reducing nitrate concentration in the saliva [<xref ref-type="bibr" rid="CR31">31</xref>]<bold>.</bold></p>
              <p id="Par16">Traditional plant-based mouthwashes reduce unwanted reactions to chemicals such as antibiotic resistance and gradual decay or staining of teeth [<xref ref-type="bibr" rid="CR18">18</xref>]<bold>.</bold> Herbal mouthwashes are produced from natural substances and have fewer side effects; they also have antibacterial, antiviral, and antifungal properties; therefore, their use has become widespread in the last decade [<xref ref-type="bibr" rid="CR32">32</xref>]. The antibacterial effect of plant extracts and herbal mouthwashes against microorganisms responsible for bacterial infection of the oral cavity is attributed to the presence of compounds such as glycosides, terpenoids, flavonoids, and saponins [<xref ref-type="bibr" rid="CR33">33</xref>]<bold>.</bold></p>
              <p id="Par17">Herbal mouthwashes containing cloves (<italic>Eugenia caryophyllata</italic> belonging to the Myrtaceae family) are used for oral cooling and in toothpastes and to treat oral diseases and toothache [<xref ref-type="bibr" rid="CR34">34</xref>], or thousands of years, clove has been used as a traditional medicinal plant to treat gum infection due to its antimicrobial activities against oral bacteria [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]<bold>.</bold> Eugenol, one of the main compounds of clove (81.1%), produces antibacterial, antifungal, anti-inflammatory, and antiviral effects and has been used as a disinfectant and pain reliever in traditional medicines [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Clove has antimicrobial activities against oral bacteria and periodontal disease [<xref ref-type="bibr" rid="CR36">36</xref>]<bold>.</bold> In the study by Mostaqim et al. (2019) in Bangladesh, the antibacterial efficacy of clove was demonstrated against gram-positive bacteria (<italic>Staphylococcus aureus</italic>) and gram-negative bacteria (<italic>Escherichia coli</italic> and <italic>Pseudomonas aeruginosa</italic>) [<xref ref-type="bibr" rid="CR38">38</xref>]. The study by Purkait et al. (2020) in Germany showed the antibacterial and antifungal effects of combined clove and cinnamon on <italic>Staphylococcus aureus</italic>, <italic>Salmonella typhi</italic>, and <italic>Pseudomonas aeruginosa</italic> [<xref ref-type="bibr" rid="CR39">39</xref>]. The study by Bharadwaj (2020) in India revealed the activity of the phytochemicals in clove extract and their antibacterial efficacy against <italic>Escherichia coli</italic>, <italic>Klebsiella pneumoniae</italic>, <italic>Pseudomonas aeruginosa</italic>, <italic>Salmonella typhi</italic>, <italic>Bacillus subtilis</italic>, and <italic>Staphylococcus aureus</italic> [<xref ref-type="bibr" rid="CR34">34</xref>]. Oral care is extensively used in the ICU for the prevention of VAP, and its effectiveness has been confirmed, but the exact details of its operational processes still require further discussion. So far, there is no gold standard recommendation for the scrubs used in oral care [<xref ref-type="bibr" rid="CR40">40</xref>]. There is also no consensus on the best way of providing optimal oral health care in the critically ill. More research is required to standardize oral health assessment and care practices and thus develop evidence-based, individualized, oral care protocols for the critically ill [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. The British Association of Critical Nurses (BACCN) has also emphasized the need for further research on this topic [<xref ref-type="bibr" rid="CR42">42</xref>]. The hypothesis of the present study was that clove mouthwash is effective in the incidence of VAP in MV patients. Therefore, the aim of the present study was to investigate the effect of clove mouthwash on the incidence of VAP in ICU patients.</p>
            </sec>
            <sec id="Sec2">
              <title>Methods
</title>
              <sec id="Sec3">
                <title>Study design</title>
                <p id="Par18">This study was a comparative, randomized, triple-blind, clinical trial. The patients, the nurse who performed the mouthwash for them, the pulmonologist who made the diagnosis of VAP, and the statistician who carried out the data analysis were all blinded to the group allocations.</p>
              </sec>
              <sec id="Sec4">
                <title>Inclusion criteria</title>
                <p id="Par19">The inclusion criteria consisted of age over 18 years, recent admission to the ICU and having undergone MV for more than 48 h, lack of aspiration symptoms or VAP with a Modified Clinical Pulmonary Infection Score (MCPIS) &lt;6 on the first day, no COVID-19 infection, no face and mouth trauma, no contraindications for elevating the head of the bed by 30°, no contraindications for oral care, and no history of allergy to chlorhexidine 0.2%.</p>
              </sec>
              <sec id="Sec5">
                <title>Exclusion criteria</title>
                <p id="Par20">The exclusion criteria were removal from MV at less than 48 h, fever of 38.5 °C and higher during the first 24 h after intubation, positive polymerase chain reaction (PCR) test (COVID-19 infection), more than three attempts at intubation, and APACHE II score &gt; 30.</p>
              </sec>
              <sec id="Sec6">
                <title>Participants</title>
                <p id="Par21">The study samples were the patients admitted to the internal and surgical ICUs of Kosar Hospital in Semnan in 2021–2022 who were connected to a mechanical ventilator and met the inclusion criteria.</p>
              </sec>
              <sec id="Sec7">
                <title>Sample size</title>
                <p id="Par22">In a preliminary study consisting of 70 people in each group, 21.4% of patients receiving clove mouthwash and 41.4% of patients receiving chlorhexidine developed VAP (MCPIS score 6 or more). Considering 95% confidence and 80% power, the sample size was estimated to be 84 patients for each group.
<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n=\frac{2{\left({Z}_{1-\frac{\alpha }{2}}+{Z}_{1-\beta }\right)}^{2}P\left(1-P\right)}{{\left({P}_{1}-{P}_{2}\right)}^{2}}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:mfenced close=")" open="("><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>β</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>P</mml:mi><mml:mfenced close=")" open="("><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>P</mml:mi></mml:mfenced></mml:mrow><mml:msup><mml:mrow><mml:mfenced close=")" open="("><mml:msub><mml:mi>P</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="784_2023_4972_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
              </sec>
              <sec id="Sec8">
                <title>Randomization</title>
                <p id="Par23">The patients who met the inclusion criteria were assigned to either intervention (A) or control (B) groups using random blocks. The possible states of allocation to either of the two blocks, i.e., AB or BA, were written on a card. Given that age and gender were confounding variables, after randomly choosing the first patient and assigning them to either of the blocks, the next patient, who could differ in age with the first patient by a maximum of 5 years, was assigned to the opposite group; otherwise, they waited for their turn in the next block. As for gender, stratified randomization was used—that is, randomization was done separately for men and women. In other words, each two female patients referring to the hospital consecutively were divided according to the above classifications in advance. The same was performed for male patients until sampling was completed.</p>
              </sec>
              <sec id="Sec9">
                <title>Data collection instrument</title>
                <p id="Par24">Data were collected using a demographic questionnaire, VAP severity was measured based on the Acute Physiology and Chronic Health Evaluation II (APACHE II) score, oral hygiene status was determined using Beck Oral Assessment Scale (BOAS), and VAP diagnosis was made based on the Modified Clinical Pulmonary Infection Score (MCPIS).</p>
              </sec>
              <sec id="Sec10">
                <title>Demographic questionnaire</title>
                <p id="Par25">
The demographic questionnaire consisted of items on age, gender, occupation, underlying diseases; reason for ICU admission and ward from which ICU referral was made; ward where endotracheal intubation had been carried out; disease severity based on the APACHE II score; use of medications such as antibiotics, beta-blockers, antihistamines, diuretics, atropine, bronchodilators, immunosuppressants, and sedatives for dry mouth (xerostomia); history of smoking; score on the Glasgow Coma Scale; repeated attempts to perform intubation; accidental removal of the tracheal tube; MV parameters; the amount of PEEP used; the amount of pressure support; mode of MV device during hospitalization; spontaneous breathing and its duration; MV duration; ICU length of stay; and presence of nasogastric tube, gastric residual, and endotracheal tube cuff pressure.</p>
              </sec>
              <sec id="Sec11">
                <title>Acute physiology and chronic health evaluation II (APACHE II)</title>
                <p id="Par26">The severity of the disease was measured using APACHE II criteria (Knaus et al., 1985) [<xref ref-type="bibr" rid="CR43">43</xref>]. The APACHE II scoring system is a disease severity classification system and one of the most widely used scores in the ICU [<xref ref-type="bibr" rid="CR44">44</xref>]. The score is calculated by measuring 12 physiological variables, age, and health status. The 12 physiological variables include body temperature, mean arterial pressure, heart rate, respiration rate, ratio of arterial oxygen partial pressure (Pao<sub>2</sub>) to fractional inspired oxygen (FiO<sub>2</sub>) (Pao<sub>2</sub>/FiO<sub>2</sub> ratio), arterial pH, arterial HCO<sub>3</sub>, serum sodium level, serum potassium, hematocrit, creatinine, and leukocytes [<xref ref-type="bibr" rid="CR44">44</xref>], and the total score ranges from 0 to 4. This scoring system works by focusing on the most unusual measurements and values in the first 24 h of ICU admission. The consciousness level was scored using the Glasgow Coma Scale. Scoring in the second (adjustment of age) and third (adjustment of underlying disease) parts was performed based on the specific classification from the APACHE II score form [<xref ref-type="bibr" rid="CR45">45</xref>]. As for disease severity, APACHE II score &lt; 16 was indicative of low, 16–25 moderate, 26–30 severe, and &gt; 30 extremely severe disease [<xref ref-type="bibr" rid="CR29">29</xref>]. This tool has acceptable validity and reliability [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
              </sec>
              <sec id="Sec12">
                <title>Beck oral assessment scale (BOAS)</title>
                <p id="Par27">The oral health status of the patients was evaluated using BOAS scale. BOAS has been proposed as the most appropriate tool for use among ICU patients, with the mucosal-dental plaque score being the most applicable during observation [<xref ref-type="bibr" rid="CR47">47</xref>], with five criteria, including the lips, gingival and oral mucosa membrane, tongue, teeth, and saliva. Each criterion was assigned a score from 1 to 4, so that the total score ranged from 5 to 20. The absence of disorder was scored as 5, mild disorder as 6–10, moderate disorder as 11–15, and severe disorder as 16–20 [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. This scoring system has satisfactory validity and reliability [<xref ref-type="bibr" rid="CR49">49</xref>].</p>
              </sec>
              <sec id="Sec13">
                <title>Modified clinical pulmonary infection score (MCPIS)</title>
                <p id="Par28">The diagnosis of VAP was made using the MCPIS by Fartukh et al. (2003) [<xref ref-type="bibr" rid="CR50">50</xref>]. In this scoring system, the maximum score is 10, where MCPIS &lt; 6 indicates the absence of VAP and MCPIS ≥ 6 indicates the presence of VAP. This system has been approved by the American Thoracic Society and the Infectious Diseases Society of America [<xref ref-type="bibr" rid="CR11">11</xref>]. This scale evaluates five parameters, including body temperature, white blood cell count, secretions, the Pao<sub>2</sub>/FiO<sub>2</sub> ratio, and chest X-ray. For each of these five parameters, based on the patient’s condition, a score of 0 to 2 is assigned, where 0 represents normal conditions and 1 and 2 represent lack of normal conditions. Body temperature was measured in the armpit. Temperatures of 36.5–38.4 °C received a score of 0, 38.5–39 °C a score of 1, and &gt; 39 °C a score of 2. A white blood cell count of 4000–11,000 was given a score of 0, 11,000–17,000 score of 1, and over 17,000 score of 2. If the patient did not have secretions or was normal, they would be assigned a score of 0, and if they had secretions, they would be assigned a score of 1 or 2 depending on the amount of secretions and the physician’s opinion. The Pao<sub>2</sub>/FiO<sub>2</sub> ratio was calculated by examining the arterial gasses and oxygen percentage set for MV. A ratio more than 200 was scored as 0, and a ratio less than 200 was scored as 2. The chest X-rays were checked by the physician. If the X-ray showed no problems, it was scored as 0, and X-rays containing scattered spots were scored as 1 and those with concentrated spots as 2. The scores of all the parameters were summed up, with the total score ranging from 0 to10. On the 1st and 5th days, the patients were examined for VAP by a pulmonologist using the MCPIS, and those with a score ≥ 6 were regarded as a case of VAP [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. This scale has demonstrated acceptable validity and reliability [<xref ref-type="bibr" rid="CR11">11</xref>]<bold>.</bold></p>
              </sec>
              <sec id="Sec14">
                <title>Protocol</title>
                <p id="Par29">Clove mouthwash solution at 6.66% concentration (Dr. Jahangir Pharmaceutical and Hygienic Co., Lorestan, Iran) and chlorhexidine 0.2% (Donyaye Behdasht Pharmaceutical Co., Tehran, Iran) were blindly provided to the ICU nurse by the researcher, and the nurse applied the mouthwash using 4–6 swabs.</p>
                <p id="Par30">In the intervention group, mouthwash was applied with 15 ml of clove extract at 6.66% concentration twice a day at 8:00 a.m. and 4:00 p.m. for 5 days.</p>
                <p id="Par31">In the control group, mouthwash was applied with 15 ml of chlorhexidine 0.2% (routine care) twice a day at 8:00 a.m. and 4:00 p.m. for 5 days.</p>
                <p id="Par32">The first mouthwash was applied by a trained ICU nurse within the first 24 h of hospitalization and then on the second, third, fourth, and fifth days. The conditions of the procedure were the same in both groups. After washing the hands, to prevent the aspiration of secretions, the head of the patient’s bed was elevated by 30°, and the patient was positioned semi-sitting. Tracheal tube cuff pressure was measured using Covidien (Medtronic, Germany) and was maintained at 25 cm H<sub>2</sub>O. Using sterile gloves, the nurse soaked 4–6 swabs (depending on the patient’s oral hygiene status) with the solutions prepared for the intervention and control groups and washed the mucous membrane of their mouth, tongue and gums, and then suctioned the excess secretions. The suction conditions were the same for both groups [<xref ref-type="bibr" rid="CR51">51</xref>]. Finally, the tape around the tracheal tube was replaced, the lips were cleaned, and some Vaseline was applied to lubricate the lip surface using an applicator. On the 1st and 5th days, the patients were examined for VAP using the MCPIS. A score of ≥ 6 was taken as having acquired VAP (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow chart of the study design, enrollment, allocation, randomization, follow-up, and analyzed of study patients</p></caption><graphic xlink:href="784_2023_4972_Fig1_HTML" id="MO1"/></fig></p>
              </sec>
              <sec id="Sec15">
                <title>Data analysis</title>
                <p id="Par33">The data obtained were analyzed using the Kolmogorov–Smirnov test, Mann–Whitney <italic>U</italic>-test, chi-square test, Fisher’s exact test, and the relative risk (RR) calculation at 95% CI in SPSS version 24, and the significance level (<italic>p</italic> value) was set at &lt; 0.05.</p>
              </sec>
              <sec id="Sec16">
                <title>Ethical considerations</title>
                <p id="Par34">An ethics code was obtained at Semnan University of Medical Sciences, and the study protocol was registered at the Iranian Registry of Clinical Trials. Necessary permissions were also obtained from the hospital and ICU authorities of Kosar Hospital. Before beginning the study procedure, the patient companions were briefed on the study objectives and procedure, and they then provided written informed consent for the patients’ participation in the study.</p>
              </sec>
            </sec>
            <sec id="Sec17">
              <title>Results</title>
              <sec id="Sec18">
                <title>Patients’ demographics</title>
                <p id="Par35">The mean ± standard deviation of age was 55.21 ± 9.7 and 59.7 ± 21.4 years in the intervention and control groups. The distribution of age (<italic>p</italic> = 0.267), gender (<italic>p</italic> = 0.419), occupation (<italic>p</italic> = 0.170), underlying disease (<italic>p</italic> &gt; 0.05), medication use (<italic>p</italic> &gt; 0.05), smoking (<italic>p</italic> = 0.278), disease severity (<italic>p</italic> = 0.412), oral hygiene status (<italic>p</italic> = 0.239), consciousness level (<italic>p</italic> = 0.819), reason for hospitalization (<italic>p</italic> = 0.236), ward from which ICU referral was made (<italic>p</italic> = 0.416), ward where intubation had been performed (<italic>p</italic> = 0.223), and pressure support (<italic>p</italic> = 0.736) did not differ significantly between the two groups (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of the patients </p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristic</th><th align="left" rowspan="2"/><th align="left" colspan="2">Intervention (<italic>n</italic> = 84)</th><th align="left" colspan="2">Control (<italic>n</italic> = 84)</th><th align="left"><italic>p</italic> value</th></tr><tr><th align="left"><italic>n</italic></th><th align="left">%</th><th align="left"><italic>n</italic></th><th align="left">%</th><th align="left"/></tr></thead><tbody><tr><td align="left" rowspan="2">Gender</td><td align="left">Male</td><td align="left">52</td><td align="left">61.9</td><td align="left">57</td><td align="left">67.9</td><td align="left" rowspan="2">0.419*</td></tr><tr><td align="left">Female</td><td align="left">32</td><td align="left">38.1</td><td align="left">27</td><td align="left">32.1</td></tr><tr><td align="left" rowspan="3">Age</td><td align="left"> &lt; 40</td><td align="left">24</td><td align="left">28.6</td><td align="left">18</td><td align="left">21.4</td><td align="left" rowspan="3">0.267**</td></tr><tr><td align="left">40–59</td><td align="left">14</td><td align="left">16.7</td><td align="left">18</td><td align="left">21.4</td></tr><tr><td align="left"> ≥ 60</td><td align="left">46</td><td align="left">54.8</td><td align="left">48</td><td align="left">57.1</td></tr><tr><td align="left" rowspan="4">Occupation</td><td align="left">Free</td><td align="left">13</td><td align="left">15.5</td><td align="left">19</td><td align="left">22.6</td><td align="left"/></tr><tr><td align="left">Retired</td><td align="left">20</td><td align="left">23.8</td><td align="left">27</td><td align="left">32.1</td><td align="left">0.170*</td></tr><tr><td align="left">Unemployed</td><td align="left">34</td><td align="left">40.5</td><td align="left">29</td><td align="left">34.5</td><td align="left"/></tr><tr><td align="left">Others</td><td align="left">17</td><td align="left">20.2</td><td align="left">9</td><td align="left">10.7</td><td align="left"/></tr><tr><td align="left" rowspan="5">Underlying disease</td><td align="left">Diabetes</td><td align="left">31</td><td align="left">36.9</td><td align="left">33</td><td align="left">39.3</td><td align="left">0.751<italic>*</italic></td></tr><tr><td align="left">Hypertension</td><td align="left">29</td><td align="left">34.5</td><td align="left">36</td><td align="left">42.9</td><td align="left">0.267*</td></tr><tr><td align="left">Digestive</td><td align="left">2</td><td align="left">2.4</td><td align="left">2</td><td align="left">2.4</td><td align="left">1.00<italic>***</italic></td></tr><tr><td align="left">Cardiac</td><td align="left">20</td><td align="left">23.8</td><td align="left">19</td><td align="left">22.6</td><td align="left">0.855<italic>*</italic></td></tr><tr><td align="left">Other diseases</td><td align="left">17</td><td align="left">20.2</td><td align="left">20</td><td align="left">23.8</td><td align="left">0.576<italic>*</italic></td></tr><tr><td align="left" rowspan="6">Medical use</td><td align="left">Antibiotics</td><td align="left">83</td><td align="left">98.8</td><td align="left">82</td><td align="left">97.6</td><td align="left">1.00***</td></tr><tr><td align="left">Beta blockers</td><td align="left">43</td><td align="left">51.2</td><td align="left">52</td><td align="left">61.9</td><td align="left">0.161<italic>*</italic></td></tr><tr><td align="left">Diuretics</td><td align="left">35</td><td align="left">41.7</td><td align="left">40</td><td align="left">47.6</td><td align="left">0.438<italic>*</italic></td></tr><tr><td align="left">Atropine</td><td align="left">0</td><td align="left">0</td><td align="left">2</td><td align="left">2.4</td><td align="left">0.497<italic>***</italic></td></tr><tr><td align="left">Bronchodilators</td><td align="left">39</td><td align="left">46.4</td><td align="left">41</td><td align="left">48.8</td><td align="left">0.757<italic>*</italic></td></tr><tr><td align="left">Sedative</td><td align="left">83</td><td align="left">98.8</td><td align="left">84</td><td align="left">100</td><td align="left">1.00<italic>***</italic></td></tr><tr><td align="left" rowspan="2">Smoking</td><td align="left">Yes</td><td align="left">35</td><td align="left">41.7</td><td align="left">42</td><td align="left">50.0</td><td align="left" rowspan="2">0.278*</td></tr><tr><td align="left">No</td><td align="left">49</td><td align="left">58.3</td><td align="left">42</td><td align="left">50.0</td></tr><tr><td align="left" rowspan="3">APACHE II</td><td align="left"> &gt; 16</td><td align="left">53</td><td align="left">63.1</td><td align="left">49</td><td align="left">58.3</td><td align="left" rowspan="3">0.412**</td></tr><tr><td align="left">16–25</td><td align="left">28</td><td align="left">33.3</td><td align="left">32</td><td align="left">38.1</td></tr><tr><td align="left">26–30</td><td align="left">3</td><td align="left">3.6</td><td align="left">3</td><td align="left">3.6</td></tr><tr><td align="left" rowspan="3">Glasgow Coma Scale</td><td align="left">3–5</td><td align="left">10</td><td align="left">11.9</td><td align="left">14</td><td align="left">16.7</td><td align="left" rowspan="3">0.819**</td></tr><tr><td align="left">6–8</td><td align="left">49</td><td align="left">58.3</td><td align="left">47</td><td align="left">56.0</td></tr><tr><td align="left">9–11</td><td align="left">25</td><td align="left">29.8</td><td align="left">23</td><td align="left">27.4</td></tr><tr><td align="left" rowspan="3">BOAS</td><td align="left"> ≤ 5</td><td align="left">13</td><td align="left">15.5</td><td align="left">20</td><td align="left">23.8</td><td align="left" rowspan="3">0.239**</td></tr><tr><td align="left">6–10</td><td align="left">71</td><td align="left">84.5</td><td align="left">63</td><td align="left">75</td></tr><tr><td align="left">11–15</td><td align="left">0</td><td align="left">0</td><td align="left">1</td><td align="left">1.2</td></tr><tr><td align="left" rowspan="6">Reason for ICU admission</td><td align="left">Trauma</td><td align="left">25</td><td align="left">29.8</td><td align="left">23</td><td align="left">27.4</td><td align="left" rowspan="6">0.236*</td></tr><tr><td align="left">Brain problems</td><td align="left">11</td><td align="left">13.1</td><td align="left">9</td><td align="left">10.7</td></tr><tr><td align="left">Heart problems</td><td align="left">1</td><td align="left">1.2</td><td align="left">4</td><td align="left">4.8</td></tr><tr><td align="left">Lung problems</td><td align="left">9</td><td align="left">10.7</td><td align="left">7</td><td align="left">8.3</td></tr><tr><td align="left">Loss of consciousness</td><td align="left">32</td><td align="left">38.1</td><td align="left">40</td><td align="left">47.6</td></tr><tr><td align="left">Other diseases</td><td align="left">6</td><td align="left">7.1</td><td align="left">1</td><td align="left">1.2</td></tr><tr><td align="left" rowspan="3">Referral ward to ICU</td><td align="left">Emergency</td><td align="left">72</td><td align="left">85.7</td><td align="left">70</td><td align="left">83.3</td><td align="left" rowspan="3">0.416*</td></tr><tr><td align="left">Internal</td><td align="left">9</td><td align="left">10.7</td><td align="left">13</td><td align="left">15.5</td></tr><tr><td align="left">Other departments</td><td align="left">3</td><td align="left">3.6</td><td align="left">1</td><td align="left">1.2</td></tr><tr><td align="left" rowspan="3">Intubation ward</td><td align="left">ICU</td><td align="left">41</td><td align="left">48.8</td><td align="left">52</td><td align="left">61.9</td><td align="left" rowspan="3">0.223*</td></tr><tr><td align="left">Emergency</td><td align="left">41</td><td align="left">48.8</td><td align="left">30</td><td align="left">35.7</td></tr><tr><td align="left">Internal</td><td align="left">2</td><td align="left">2.4</td><td align="left">2</td><td align="left">2.4</td></tr><tr><td align="left" rowspan="3">Support pressure</td><td align="left">0–5</td><td align="left">1</td><td align="left">1.2</td><td align="left">5</td><td align="left">6.0</td><td align="left" rowspan="3">0.736**</td></tr><tr><td align="left">6–10</td><td align="left">48</td><td align="left">57.1</td><td align="left">45</td><td align="left">53.6</td></tr><tr><td align="left">11–15</td><td align="left">35</td><td align="left">41.7</td><td align="left">34</td><td align="left">40.5</td></tr></tbody></table><table-wrap-foot><p>*Chi-square</p><p>**Mann–Whitney <italic>U</italic>-test</p><p>***Fisher’s exact</p><p><italic>APACHE II</italic> Acute Physiology and Chronic Health Evaluation II, <italic>BOAS</italic> Beck Oral Assessment Scale</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec19">
                <title>Outcome measures</title>
                <p id="Par36">APACHE II score was determined based on the physiological score (<italic>p</italic> = 0.414), age (<italic>p</italic> = 0.324), and underlying disease (<italic>p</italic> = 0.642), and there was no significant difference between the intervention and control groups in this regard (Table <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Characteristics of the APACHE II in intervention and control groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristics</th><th align="left">Intervention (<italic>n</italic> = 84)</th><th align="left">Control (<italic>n</italic> = 84)</th><th align="left" rowspan="2"><italic>p</italic> value*</th></tr><tr><th align="left">Median (Q1, Q3)</th><th align="left">Median (Q1, Q3)</th></tr></thead><tbody><tr><td align="left">Physiology score</td><td align="left">9.50 (6.25, 12.00)</td><td align="left">10.00 (7.00, 12.00)</td><td char="." align="char">0.414</td></tr><tr><td align="left">Age score</td><td align="left">3.00 (0.00, 5.00)</td><td align="left">3.00 (0.00, 6.00)</td><td char="." align="char">0.324</td></tr><tr><td align="left">Underlying disease</td><td align="left">1.00 (0.00, 2.00)</td><td align="left">1.00 (0.00, 2.00)</td><td char="." align="char">0.642</td></tr><tr><td align="left">APACHE II</td><td align="left">14.00 (10.00, 18.00)</td><td align="left">14.00 (11.00, 18.00)</td><td char="." align="char">0.412</td></tr></tbody></table><table-wrap-foot><p>*Mann–Whitney <italic>U</italic>-test</p></table-wrap-foot></table-wrap></p>
                <p id="Par37">The baseline BOAS score (<italic>p</italic> = 0.239) for the lips (<italic>p</italic> = 0.018), gingival and oral mucous membrane (<italic>p</italic> = 0.116), tongue (<italic>p</italic> = 0.651), teeth (<italic>p</italic> = 0.074), and saliva (<italic>p</italic> = 0.673) showed no significant differences between the intervention and control groups (Table <xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Characteristics of the BOAS in intervention and control groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristics</th><th align="left">Intervention (<italic>n</italic> = 84)</th><th align="left">Control (<italic>n</italic> = 84)</th><th align="left" rowspan="2"><italic>p</italic> value*</th></tr><tr><th align="left">Median (Q1, Q3)</th><th align="left">Median (Q1, Q3)</th></tr></thead><tbody><tr><td align="left">Baseline BOAS, lips</td><td align="left">1.00 (1.00, 2.00)</td><td align="left">2.00 (1.00, 2.00)</td><td char="." align="char">0.018</td></tr><tr><td align="left">Baseline BOAS, gingival and oral mucosa</td><td align="left">1.00 (1.00, 1.00)</td><td align="left">1.00 (1.00, 1.00)</td><td char="." align="char">0.116</td></tr><tr><td align="left">Baseline BOAS, tongue</td><td align="left">1.00 (1.00, 1.00)</td><td align="left">1.00 (1.00, 1.00)</td><td char="." align="char">0.651</td></tr><tr><td align="left">Baseline BOAS, teeth</td><td align="left">1.00 (1.00, 1.00)</td><td align="left">1.00 (1.00, 1.00)</td><td char="." align="char">0.074</td></tr><tr><td align="left">Baseline BOAS, saliva</td><td align="left">2.00 (1.00, 2.00)</td><td align="left">2.00 (1.00, 2.00)</td><td char="." align="char">0.673</td></tr><tr><td align="left">BOAS</td><td align="left">6.00 (6.00, 7.00)</td><td align="left">7.00 (6.00, 7.00)</td><td char="." align="char">0.239</td></tr></tbody></table><table-wrap-foot><p>*Mann–Whitney <italic>U</italic>-test</p></table-wrap-foot></table-wrap></p>
                <p id="Par38">MCPIS for body temperature (<italic>p</italic> = 0.234), white blood cell count (<italic>p</italic> = 0.249), the PaO<sub>2</sub>/FiO<sub>2</sub> ratio (<italic>p</italic> = 0.530), and chest X-ray (<italic>p</italic> = 0.097) showed no significant differences between the two groups; however, MCPIS (<italic>p</italic> = 0.002) and the secretions score (<italic>p</italic> = 0.008) differed significantly between the intervention and control groups (Table <xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Characteristics of the MCPIS in intervention and control groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristics</th><th align="left">Intervention (<italic>n</italic> = 84)</th><th align="left">Control (<italic>n</italic> = 84)</th><th align="left" rowspan="2"><italic>p</italic> value*</th></tr><tr><th align="left">Median (Q1, Q3)</th><th align="left">Median (Q1, Q3)</th></tr></thead><tbody><tr><td align="left">Body temperature</td><td align="left">0.00 (0.00, 0.00)</td><td align="left">0.00 (0.00, 0.75)</td><td char="." align="char">0.234</td></tr><tr><td align="left">White blood cell count</td><td align="left">1.00 (0.00, 1.00)</td><td align="left">1.00 (0.00, 1.00)</td><td char="." align="char">0.249</td></tr><tr><td align="left">Secretions</td><td align="left">1.00 (1.00, 1.00)</td><td align="left">1.00 (1.00, 2.00)</td><td char="." align="char">0.008</td></tr><tr><td align="left">Pao<sub>2</sub>/FiO<sub>2</sub> ratio</td><td align="left">2.00 (2.00, 2.00)</td><td align="left">2.00 (2.00, 2.00)</td><td char="." align="char">0.530</td></tr><tr><td align="left">Chest X-ray</td><td align="left">0.00 (0.00, 1.00)</td><td align="left">0.00 (0.00, 2.00)</td><td char="." align="char">0.097</td></tr><tr><td align="left">MCPIS</td><td align="left">4.00 (3.00, 5.00)</td><td align="left">5.00 (3.25, 7.00)</td><td char="." align="char">0.002</td></tr></tbody></table><table-wrap-foot><p>*Mann–Whitney <italic>U</italic>-test</p></table-wrap-foot></table-wrap></p>
                <p id="Par39">After the intervention, 20.2% (<italic>n</italic> = 17) of the patients in the intervention group and 41.7% (<italic>n</italic> = 35) in the control group acquired VAP. The incidence rate of VAP was 2.06 times higher in the control group than in the intervention group (RR = 2.06, 95% CI: 1.26–3.37, <italic>p</italic> = 0.005) (Table <xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab5"><label>Table 5</label><caption><p>Incidence of VAP in intervention and control groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">VAP</th><th align="left" colspan="2">Intervention (<italic>n</italic> = 84)</th><th align="left" colspan="2">Control (<italic>n</italic> = 84)</th><th align="left" rowspan="2">Relative risk (RR)</th><th align="left" rowspan="2">Confidence interval 95% relative risk*</th></tr><tr><th align="left"><italic>n</italic></th><th align="left">%</th><th align="left"><italic>n</italic></th><th align="left">%</th></tr></thead><tbody><tr><td align="left">Yes</td><td align="left">17</td><td align="left">20.2</td><td align="left">35</td><td align="left">41.7</td><td align="left" rowspan="2">2.06</td><td align="left" rowspan="2">1.26–3.37</td></tr><tr><td align="left">No</td><td align="left">67</td><td align="left">79.8</td><td align="left">49</td><td align="left">58.3</td></tr><tr><td align="left">Total</td><td align="left">84</td><td align="left">100</td><td align="left">84</td><td align="left">100</td><td align="left">-</td><td align="left">-</td></tr></tbody></table><table-wrap-foot><p>*Chi-square
</p></table-wrap-foot></table-wrap></p>
                <p id="Par40">There was no significant difference in VAP severity between the two groups (<italic>p</italic> = 0.557) (Table <xref rid="Tab6" ref-type="table">6</xref>).<table-wrap id="Tab6"><label>Table 6</label><caption><p>Severity of VAP in intervention and control groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Severity of VAP</th><th align="left" colspan="2">Intervention</th><th align="left" colspan="2">Control</th><th align="left" rowspan="2"><italic>p</italic> value*</th></tr><tr><th align="left"><italic>n</italic></th><th align="left">%</th><th align="left"><italic>n</italic></th><th align="left">%</th></tr></thead><tbody><tr><td align="left">6</td><td align="left">8</td><td align="left">47.0</td><td align="left">12</td><td align="left">34.3</td><td align="left" rowspan="4">0.557</td></tr><tr><td align="left">7</td><td align="left">7</td><td align="left">41.2</td><td align="left">20</td><td align="left">57.1</td></tr><tr><td align="left">8</td><td align="left">1</td><td align="left">5.9</td><td align="left">3</td><td align="left">8.6</td></tr><tr><td align="left">9</td><td align="left">1</td><td align="left">5.9</td><td align="left">-</td><td align="left">-</td></tr><tr><td align="left">Total</td><td align="left">17</td><td align="left">100</td><td align="left">35</td><td align="left">100</td><td align="left">-</td></tr></tbody></table><table-wrap-foot><p>*Mann–Whitney <italic>U</italic>-test
</p></table-wrap-foot></table-wrap></p>
              </sec>
            </sec>
            <sec id="Sec20">
              <title>Discussion</title>
              <p id="Par41">The results of this study showed that 20.2% of the patients in the intervention group and 41.7% of those in the control group acquired VAP. The risk of VAP was 2.06 times higher in the control group than in the intervention group. In line with the present findings, various other studies have also demonstrated the antibacterial and antimicrobial effects of clove. A study by Rajeshkumar et al. (2022) in India showed that chamomile and clove mouthwash has an optimal, dose-dependent, inhibitory role against <italic>Streptococcus mutans</italic>; therefore, chamomile and clove mouthwash could be a safe alternative for infections caused by <italic>S. mutans</italic> [<xref ref-type="bibr" rid="CR52">52</xref>]. A study by Gupta et al. (2021) in India also revealed the antimicrobial activity of clove against the main bacterial causes of dental plaque, including <italic>Pseudomonas</italic>, <italic>Lactobacillus</italic>, and <italic>Streptococcus mutans</italic>; clove thus has the potential to be used as a natural antibacterial agent for oral pathogens [<xref ref-type="bibr" rid="CR53">53</xref>]. A study by Ahmed et al. (2021) in Pakistan also showed that clove strongly affects the growth of different streptococcus species causing tooth decay [<xref ref-type="bibr" rid="CR54">54</xref>]. A study by Sahu et al. (2020) in India showed that clove extract contains some compounds such as acetyleugenol, beta-caryophyllene, and vanillin which can be effective in the treatment of bronchitis [<xref ref-type="bibr" rid="CR55">55</xref>]. A study by Green et al. (2020) further demonstrated the antiviral effect of clove extract by directly affecting the respiratory syncytial virus and eliminating its infectious properties [<xref ref-type="bibr" rid="CR56">56</xref>]. A study by Nirmala et al. (2019) in India demonstrated the antimicrobial properties of clove against <italic>Staphylococcus aureus</italic> [<xref ref-type="bibr" rid="CR37">37</xref>]. The study by Faujdar et al. (2020) in India revealed the antibacterial effects of clove extract on gram-negative bacteria [<xref ref-type="bibr" rid="CR57">57</xref>]. Microscopic examinations carried out in a study by Wongsawan et al. (2020) in Thailand also showed the inability of <italic>Streptococcus</italic> to grow and its cell membrane disruption upon exposure to clove [<xref ref-type="bibr" rid="CR58">58</xref>]. Furthermore, a study by Bharadwaj et al. (2020) in India showed the antimicrobial and phytochemical activity of clove against <italic>Escherichia coli</italic>, <italic>Klebsiella pneumoniae</italic>, <italic>Pseudomonas aeruginosa</italic>, <italic>Salmonella typhi</italic>, <italic>Bacillus subtilis</italic>, and <italic>Staphylococcus aureus</italic> [<xref ref-type="bibr" rid="CR34">34</xref>]. In addition, the study by Yassin et al. (2020) in Saudi Arabia revealed that clove is an effective, natural, and safe antifungal agent producing inhibitory effects against the most common and dominant types of candidiasis [<xref ref-type="bibr" rid="CR59">59</xref>]. In contrast, a study by Mahajan (2016) in India found that the antimicrobial properties of tulsi (<italic>Ocimum tenuiflorum</italic>), clove, and neem (<italic>Azadirachta indica</italic>) mouthwash were lower compared to chlorhexidine [<xref ref-type="bibr" rid="CR60">60</xref>]. In a study by Bansal et al. (2019) in India, the antimicrobial properties of clove were found to be lower than those of chlorhexidine [<xref ref-type="bibr" rid="CR61">61</xref>]. Since the findings of the current study showed that clove mouthwash causes a significant reduction in VAP acquisition in ICU patients compared to chlorhexidine, due to the fewer side effects of herbal mouthwashes, the researchers recommend further studies as well as systematic reviews on this subject. This study showed differences in the secretions score of MCPIS between the two groups. Colonization, respiratory-digestive system and aspiration, contaminated secretions in the lower respiratory system, are two major processes responsible for VAP [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>].</p>
              <p id="Par42">The results of this study showed that the APACHE II scores did not differ significantly between the intervention and control groups. Other studies also found no statistically significant difference between the two groups regarding the APACHE-II score [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. The APACHE II score is a vital indicator of acute physiological abnormalities in patients [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. The APACHE II score is a vital indicator of acute physiological abnormalities in patients [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>].</p>
              <p id="Par43">Our research revealed that the majority of ICU patients had moderate oral health dysfunction. The results of a study by Malicka et al. (2020) in Poland showed moderate or severe dysfunction of oral health in older adults with poor oral health [<xref ref-type="bibr" rid="CR67">67</xref>]. Also, hospitalization in an ICU along with MV can be harmful to oral health and lead to the buildup of dental plaque and emergence of mucosal lesions [<xref ref-type="bibr" rid="CR68">68</xref>]. ICU patients are a group particularly susceptible to VAP because of the decline in their oral health [<xref ref-type="bibr" rid="CR69">69</xref>]. In this study, BOAS did not differ significantly between the intervention and control groups. All ICU patients are at a high risk for developing VAP, but ensuring proper oral care in ICU patients has been shown to reduce the incidence of VAP [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>].</p>
              <p id="Par44">In our study, among the patients who acquired VAP, the severity of the disease did not differ significantly between the two groups. The study by Khaki et al. (2018) in Isfahan, Iran, conducted on the efficacy of Nanosil mouthwash for the prevention of pulmonary infection in ICU patients showed a significantly higher MCPIS in the control group, who had used chlorhexidine mouthwash, and the mean MCPIS was significantly higher in the control group on the fifth day than on the first day, but the mean MCPIS in the intervention group, who had used Nanosil mouthwash, did not show significant differences between the two intervals, i.e., at days 1 and 5 [<xref ref-type="bibr" rid="CR71">71</xref>]. A comparative study by Babaiiet al. (2015) in Urmia, Iran, conducted on the effects of standard artificial airway care and routine care of the upper airway on the incidence of VAP showed that the mean MCPIS increased significantly on the third, fourth, and fifth days in the control group, who had received routine care without a specific protocol, with MCPIS increasing significantly on the fifth day compared to the third and fourth days. The mean MCPIS increased significantly on the third, fourth, and fifth days in the intervention group, but the increase was not statistically significant on the fifth day compared to the third and fourth days [<xref ref-type="bibr" rid="CR72">72</xref>].</p>
              <p id="Par45">In the present study, bronchoalveolar lavage (BAL) was not performed due to its invasiveness, despite being a reliable and definitive method for the diagnosis of VAP. In addition, it was not possible to control several factors such as antibiotic resistance, differences between the patients’ immune systems, and resistant pathogens in the environment, which could have contributed to VAP incidence. Future comparative studies are recommended on the effects of clove mouthwash and other mouthwashes for the prevention of VAP, especially in ICU patients. Clove mouthwash was more effective than chlorhexidine for VAP incidence reduction. Nurses can use clove mouthwash in their care measures to reduce VAP acquisition.</p>
            </sec>
            <sec id="Sec21">
              <title>Conclusion</title>
              <p id="Par46">The present study found that the use of clove extract mouthwash decreased the incidence of VAP in ICU patients undergoing MV compared to chlorhexidine. Therefore, clove mouthwash can be used as a simple and low-cost method to prevent VAP in ICU patients.</p>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <notes notes-type="author-contribution">
              <title>Author contribution</title>
              <p>All authors have accepted responsibility for the entire content of this manuscript and approved its submission.</p>
              <p>Mojgan Jahanshir: conceptualization, methodology, investigation, data curation, writing—original draft</p>
              <p>Monir Nobahar: conceptualization, methodology, investigation, data curation; writing—original draft, writing—review and editing, supervision, project administration</p>
              <p>Raheb Ghorbani: conceptualization, data curation; writing—original draft, writing—review and editing</p>
              <p>Farhad Malek: conceptualization, data curation; writing—original draft, writing—review and editing</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data availability</title>
              <p>The datasets generated and analyzed during the current study are not publicly available due to an agreement with the participants on the confidentiality of the data but are available from the corresponding author on reasonable request.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethical approval
</title>
                <p id="Par47">We adhered to the ethical considerations by obtaining a license from the Semnan Ethics Committee (IR.SEMUMS.REC.1399.184), on 22.09.2020, the Iran Clinical Trial Registration Center IRCT20110427006318N13, and the vice-chancellor for research at Semnan University of Medical Sciences, explaining the research objectives to the participants and obtaining their informed consent to participate in the research, ensuring them of the voluntary participation in the study and the confidentiality terms. In addition, we appreciated the cooperation of the subjects and the authorities for their cooperation with the study.</p>
              </notes>
              <notes id="FPar2" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par48">The authors declare no competing interests.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fernando</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Tran</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Klompas</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Kyeremanteng</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Mehta</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>English</surname>
                      <given-names>SW</given-names>
                    </name>
                    <name>
                      <surname>Muscedere</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Cook</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Torres</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Diagnosis of ventilator-associated pneumonia in critically ill adult patients—a systematic review and meta-analysis</article-title>
                  <source>Intensive Care Med</source>
                  <year>2020</year>
                  <volume>46</volume>
                  <fpage>1170</fpage>
                  <lpage>1179</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00134-020-06036-z</pub-id>
                  <?supplied-pmid 32306086?>
                  <pub-id pub-id-type="pmid">32306086</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <mixed-citation publication-type="other">Zhao T, Wu X, Zhang Q, Li C, Worthington HV, Hua F (n.d.) Oral hygiene care for critically ill patients to prevent ventilator‐associated pneumonia. Cochrane Database of Syst Rev 2020: 1–139. 10.1002/14651858.CD008367</mixed-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gutiérrez</surname>
                      <given-names>JMM</given-names>
                    </name>
                    <name>
                      <surname>Borromeo</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Dueño</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Paragas</surname>
                      <given-names>ED</given-names>
                    </name>
                    <name>
                      <surname>Ellasus</surname>
                      <given-names>RO</given-names>
                    </name>
                    <name>
                      <surname>Abalos-Fabia</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Abriam</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Sonido</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Hernandez</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Generale</surname>
                      <given-names>AJA</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical epidemiology and outcomes of ventilator-associated pneumonia in critically ill adult patients: protocol for a large-scale systematic review and planned meta-analysis</article-title>
                  <source>Syst Rev</source>
                  <year>2019</year>
                  <volume>8</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.1186/s13643-019-1080-y</pub-id>
                  <pub-id pub-id-type="pmid">30606256</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nusrat</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Akter</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Rahman</surname>
                      <given-names>NAA</given-names>
                    </name>
                    <name>
                      <surname>Godman</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Rozario</surname>
                      <given-names>DTD</given-names>
                    </name>
                    <name>
                      <surname>Haque</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Antibiotic resistance and sensitivity pattern of metallo-β-lactamase producing gram-negative Bacilli in ventilator-associated pneumonia in the intensive care unit of a public medical school hospital in Bangladesh</article-title>
                  <source>Hosp Pract</source>
                  <year>2020</year>
                  <volume>48</volume>
                  <issue>3</issue>
                  <fpage>128</fpage>
                  <lpage>36</lpage>
                  <pub-id pub-id-type="doi">10.1080/21548331.2020.1754687</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Farag</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Tawfick</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Abozeed</surname>
                      <given-names>MY</given-names>
                    </name>
                    <name>
                      <surname>Shaban</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Abo-Shadi</surname>
                      <given-names>MA</given-names>
                    </name>
                  </person-group>
                  <article-title>Microbiological profile of ventilator-associated pneumonia among intensive care unit patients in tertiary Egyptian hospitals</article-title>
                  <source>J Infect Dev Countries</source>
                  <year>2020</year>
                  <volume>14</volume>
                  <issue>2</issue>
                  <fpage>153</fpage>
                  <lpage>161</lpage>
                  <pub-id pub-id-type="doi">10.3855/jidc.12012</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Edwardson</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Cairns</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Nosocomial infections in the ICU</article-title>
                  <source>Anaesth Intensive Care Med</source>
                  <year>2019</year>
                  <volume>20</volume>
                  <issue>1</issue>
                  <fpage>14</fpage>
                  <lpage>18</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mpaic.2018.11.004</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Papazian</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Klompas</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Luyt</surname>
                      <given-names>C-E</given-names>
                    </name>
                  </person-group>
                  <article-title>Ventilator-associated pneumonia in adults: a narrative review</article-title>
                  <source>Intensive Care Med</source>
                  <year>2020</year>
                  <volume>46</volume>
                  <issue>3</issue>
                  <fpage>886</fpage>
                  <lpage>906</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00134-020-05980-0</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ding</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Jin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Zhan</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Incidence, temporal trend and factors associated with ventilator-associated pneumonia in mainland China: a systematic review and meta-analysis</article-title>
                  <source>BMC Infect Dis</source>
                  <year>2017</year>
                  <volume>17</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="doi">10.1186/s12879-017-2566-7</pub-id>
                  <pub-id pub-id-type="pmid">28049444</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Xiao</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Incidence, risk factors, and outcomes of ventilator-associated pneumonia in traumatic brain injury: a meta-analysis</article-title>
                  <source>Neurocrit Care</source>
                  <year>2020</year>
                  <volume>32</volume>
                  <issue>1</issue>
                  <fpage>272</fpage>
                  <lpage>285</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12028-019-00773-w</pub-id>
                  <?supplied-pmid 31300956?>
                  <pub-id pub-id-type="pmid">31300956</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bonell</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Azarrafiy</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Huong</surname>
                      <given-names>VTL</given-names>
                    </name>
                    <name>
                      <surname>Viet</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Phu</surname>
                      <given-names>VD</given-names>
                    </name>
                    <name>
                      <surname>Dat</surname>
                      <given-names>VQ</given-names>
                    </name>
                    <name>
                      <surname>Wertheim</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>van Doorn</surname>
                      <given-names>HR</given-names>
                    </name>
                    <name>
                      <surname>Lewycka</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Nadjm</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>A systematic review and meta-analysis of ventilator-associated pneumonia in adults in Asia: an analysis of national income level on incidence and etiology</article-title>
                  <source>Clin Infect Dis</source>
                  <year>2019</year>
                  <volume>68</volume>
                  <issue>3</issue>
                  <fpage>511</fpage>
                  <lpage>518</lpage>
                  <pub-id pub-id-type="doi">10.1093/cid/ciy543</pub-id>
                  <?supplied-pmid 29982303?>
                  <pub-id pub-id-type="pmid">29982303</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nobahar</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Razavi</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Malek</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Ghorbani</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of hydrogen peroxide mouthwash on preventing ventilator-associated pneumonia in patients admitted to the intensive care unit</article-title>
                  <source>Braz J Infect Dis</source>
                  <year>2016</year>
                  <volume>20</volume>
                  <issue>5</issue>
                  <fpage>444</fpage>
                  <lpage>450</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bjid.2016.06.005</pub-id>
                  <?supplied-pmid 27471125?>
                  <pub-id pub-id-type="pmid">27471125</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Zhong</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Risk factors of ventilator-associated pneumonia in critically III patients</article-title>
                  <source>Front Pharmacol</source>
                  <year>2019</year>
                  <volume>10</volume>
                  <fpage>482</fpage>
                  <pub-id pub-id-type="doi">10.3389/fphar.2019.00482</pub-id>
                  <?supplied-pmid 31143118?>
                  <pub-id pub-id-type="pmid">31143118</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yekefallah</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Shafaei</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Dehghankar</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Strategies for the prevention of ventilator-associated pneumonia in the intensive care units: a review</article-title>
                  <source>J Qazvin Univ Med Sci</source>
                  <year>2019</year>
                  <volume>23</volume>
                  <issue>4</issue>
                  <fpage>352</fpage>
                  <lpage>363</lpage>
                  <pub-id pub-id-type="doi">10.32598/JQUMS.23.4.352</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jones</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Munro</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Grap</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Natural history of dental plaque accumulation in mechanically ventilated adults: a descriptive correlational study</article-title>
                  <source>Intensive Crit Care Nurs</source>
                  <year>2011</year>
                  <volume>27</volume>
                  <issue>6</issue>
                  <fpage>299</fpage>
                  <lpage>304</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.iccn.2011.08.005</pub-id>
                  <?supplied-pmid 22014582?>
                  <pub-id pub-id-type="pmid">22014582</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Needleman</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Hyun-Ryu</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Brealey</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Sachdev</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Moskal-Fitzpatrick</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Bercades</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Nagle</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Lewis</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Agudo</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Petrie</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>The impact of hospitalization on dental plaque accumulation: an observational study</article-title>
                  <source>J Clin Periodontol</source>
                  <year>2012</year>
                  <volume>39</volume>
                  <issue>11</issue>
                  <fpage>1011</fpage>
                  <lpage>1016</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1600-051X.2012.01939.x</pub-id>
                  <?supplied-pmid 22957747?>
                  <pub-id pub-id-type="pmid">22957747</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Landgraf</surname>
                      <given-names>ACM</given-names>
                    </name>
                    <name>
                      <surname>Reinheimer</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Merlin</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Couto</surname>
                      <given-names>SdAB</given-names>
                    </name>
                    <name>
                      <surname>Souza</surname>
                      <given-names>PHC</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanical ventilation and cytopathological changes in the oral mucosa</article-title>
                  <source>Am J Crit Care</source>
                  <year>2017</year>
                  <volume>26</volume>
                  <issue>4</issue>
                  <fpage>297</fpage>
                  <lpage>302</lpage>
                  <pub-id pub-id-type="doi">10.4037/ajcc2017218</pub-id>
                  <?supplied-pmid 28668915?>
                  <pub-id pub-id-type="pmid">28668915</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Takahama</surname>
                      <given-names>A</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>de Sousa</surname>
                      <given-names>VI</given-names>
                    </name>
                    <name>
                      <surname>Tanaka</surname>
                      <given-names>EE</given-names>
                    </name>
                    <name>
                      <surname>Ono</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Ito</surname>
                      <given-names>FAN</given-names>
                    </name>
                    <name>
                      <surname>Costa</surname>
                      <given-names>PP</given-names>
                    </name>
                    <name>
                      <surname>Pedriali</surname>
                      <given-names>MBBP</given-names>
                    </name>
                    <name>
                      <surname>de Lima</surname>
                      <given-names>HG</given-names>
                    </name>
                    <name>
                      <surname>Fornazieri</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Correia</surname>
                      <given-names>LS</given-names>
                    </name>
                  </person-group>
                  <article-title>Analysis of oral risk factors for ventilator-associated pneumonia in critically ill patients</article-title>
                  <source>Clin Oral Invest</source>
                  <year>2021</year>
                  <volume>25</volume>
                  <issue>3</issue>
                  <fpage>1217</fpage>
                  <lpage>1222</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00784-020-03426-x</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harput</surname>
                      <given-names>US</given-names>
                    </name>
                  </person-group>
                  <article-title>Herbal products for oral hygiene: an overview of their biological activities</article-title>
                  <source>Nat Oral Care Dent Ther</source>
                  <year>2020</year>
                  <volume>30</volume>
                  <fpage>31</fpage>
                  <lpage>44</lpage>
                  <pub-id pub-id-type="doi">10.1002/9781119618973.ch2</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ory</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Mourgues</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Raybaud</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Chabanne</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Jourdy</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Belard</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Guérin</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Cosserant</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Faure</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Calvet</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Cost assessment of a new oral care program in the intensive care unit to prevent ventilator-associated pneumonia</article-title>
                  <source>Clin Oral Invest</source>
                  <year>2018</year>
                  <volume>22</volume>
                  <issue>5</issue>
                  <fpage>1945</fpage>
                  <lpage>1951</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00784-017-2289-6</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carolina</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ferreira</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficiency of different protocols for oral hygiene combined with the use of chlorhexidine in the prevention of ventilator-associated pneumonia</article-title>
                  <source>J Bras Pneumo</source>
                  <year>2021</year>
                  <volume>47</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.36416/1806-3756/e20190286</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Silva</surname>
                      <given-names>PUJ</given-names>
                    </name>
                    <name>
                      <surname>Paranhos</surname>
                      <given-names>LR</given-names>
                    </name>
                    <name>
                      <surname>Meneses-Santos</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Blumenberg</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Macedo</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Cardoso</surname>
                      <given-names>SV</given-names>
                    </name>
                  </person-group>
                  <article-title>Combination of toothbrushing and chlorhexidine compared with exclusive use of chlorhexidine to reduce the risk of ventilator-associated pneumonia: a systematic review with meta-analysis</article-title>
                  <source>Clinics</source>
                  <year>2021</year>
                  <volume>76</volume>
                  <fpage>e2659</fpage>
                  <pub-id pub-id-type="doi">10.6061/clinics/2021/e2659</pub-id>
                  <?supplied-pmid 34133659?>
                  <pub-id pub-id-type="pmid">34133659</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Septimus</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Schweizer</surname>
                      <given-names>ML</given-names>
                    </name>
                  </person-group>
                  <article-title>Decolonization in prevention of health care-associated infections</article-title>
                  <source>Clin Microbiol Rev</source>
                  <year>2016</year>
                  <volume>29</volume>
                  <issue>2</issue>
                  <fpage>201</fpage>
                  <lpage>222</lpage>
                  <pub-id pub-id-type="doi">10.1128/CMR.00049-15</pub-id>
                  <?supplied-pmid 26817630?>
                  <pub-id pub-id-type="pmid">26817630</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kumar</surname>
                      <given-names>SB</given-names>
                    </name>
                  </person-group>
                  <article-title>Chlorhexidine mouthwash-a review</article-title>
                  <source>J Pharm Sci Res</source>
                  <year>2017</year>
                  <volume>9</volume>
                  <issue>9</issue>
                  <fpage>1450</fpage>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jackson</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Owens</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Does oral care with chlorhexidine reduce ventilator-associated pneumonia in mechanically ventilated adults?</article-title>
                  <source>Br J Nurs</source>
                  <year>2019</year>
                  <volume>28</volume>
                  <issue>11</issue>
                  <fpage>682</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.12968/bjon.2019.28.11.682</pub-id>
                  <?supplied-pmid 31188655?>
                  <pub-id pub-id-type="pmid">31188655</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chacko</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Rajan</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lionel</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Thilagavathi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Yadav</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Premkumar</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral decontamination techniques and ventilator-associated pneumonia</article-title>
                  <source>Br J Nurs</source>
                  <year>2017</year>
                  <volume>26</volume>
                  <issue>11</issue>
                  <fpage>594</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.12968/bjon.2017.26.11.594</pub-id>
                  <?supplied-pmid 28594615?>
                  <pub-id pub-id-type="pmid">28594615</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brookes</surname>
                      <given-names>ZL</given-names>
                    </name>
                    <name>
                      <surname>Bescos</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Belfield</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Ali</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Roberts</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Current uses of chlorhexidine for management of oral disease: a narrative review</article-title>
                  <source>J Dent</source>
                  <year>2020</year>
                  <volume>103</volume>
                  <fpage>103497</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.jdent.2020.103497</pub-id>
                  <?supplied-pmid 33075450?>
                  <pub-id pub-id-type="pmid">33075450</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cieplik</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Jakubovics</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Buchalla</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Maisch</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Hellwig</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Al-Ahmad</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Resistance toward chlorhexidine in oral bacteria–is there cause for concern?</article-title>
                  <source>Front Microbiol</source>
                  <year>2019</year>
                  <volume>10</volume>
                  <fpage>587</fpage>
                  <pub-id pub-id-type="doi">10.3389/fmicb.2019.00587</pub-id>
                  <?supplied-pmid 30967854?>
                  <pub-id pub-id-type="pmid">30967854</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brookes</surname>
                      <given-names>ZL</given-names>
                    </name>
                    <name>
                      <surname>Belfield</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Ashworth</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Casas-Agustench</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Raja</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pollard</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Bescos</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of chlorhexidine mouthwash on the oral microbiome</article-title>
                  <source>J Dent</source>
                  <year>2021</year>
                  <volume>113</volume>
                  <fpage>103768</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.jdent.2021.103768</pub-id>
                  <?supplied-pmid 34418463?>
                  <pub-id pub-id-type="pmid">34418463</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Anggraeni</surname>
                      <given-names>DT</given-names>
                    </name>
                    <name>
                      <surname>Hayati</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Nur’aeni</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>The effect of oral care intervention on oral health status of intubated patiant in the intensive care unit</article-title>
                  <source>Belitung Nurs J</source>
                  <year>2020</year>
                  <volume>6</volume>
                  <issue>1</issue>
                  <fpage>21</fpage>
                  <lpage>6</lpage>
                  <pub-id pub-id-type="doi">10.33546/bnj.971</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Winning</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Lundy</surname>
                      <given-names>FT</given-names>
                    </name>
                    <name>
                      <surname>Blackwood</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>McAuley</surname>
                      <given-names>DF</given-names>
                    </name>
                    <name>
                      <surname>El Karim</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral health care for the critically ill: a narrative review</article-title>
                  <source>Crit Care</source>
                  <year>2021</year>
                  <volume>25</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1186/s13054-021-03765-5</pub-id>
                  <pub-id pub-id-type="pmid">33388077</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <mixed-citation publication-type="other">Pałka Ł, Nowakowska-Toporowska A, Dalewski B, editors (n.d.) Is chlorhexidine in dentistry an ally or a foe? A narrative review. Healthcare; 2022: MDPI. 10.3390/healthcare10050764</mixed-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Batiha</surname>
                      <given-names>GE-S</given-names>
                    </name>
                    <name>
                      <surname>Alkazmi</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Wasef</surname>
                      <given-names>LG</given-names>
                    </name>
                    <name>
                      <surname>Beshbishy</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Nadwa</surname>
                      <given-names>EH</given-names>
                    </name>
                    <name>
                      <surname>Rashwan</surname>
                      <given-names>EK</given-names>
                    </name>
                  </person-group>
                  <article-title>Syzygium aromaticum L. (Myrtaceae): traditional uses, bioactive chemical constituents, pharmacological and toxicological activities</article-title>
                  <source>Biomolecules</source>
                  <year>2020</year>
                  <volume>10</volume>
                  <issue>2</issue>
                  <fpage>202</fpage>
                  <pub-id pub-id-type="doi">10.3390/biom10030352</pub-id>
                  <?supplied-pmid 32019140?>
                  <pub-id pub-id-type="pmid">32019140</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <mixed-citation publication-type="other">Yadav AR, Mohite SK, Magdum CS (2020) Preparation and evaluation of antibacterial herbal mouthwash against oral pathogens. Asian J Res Pharm Sci 10(3). 10.5958/2231-5659.2020.00028.4</mixed-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <mixed-citation publication-type="other">Bharadwaj A (n.d.) Qualitative and quantitative analysis of phytochemicals and antimicrobial activity of Syzygium aromaticum. Available at SSRN 3554164 2020: 1-14. 10.2139/ssrn.3554164</mixed-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hepokur</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Investigation of cytotoxic effects of Eugenia caryophyllus (Clove)</article-title>
                  <source>Cumhuriyet Dent J</source>
                  <year>2018</year>
                  <volume>21</volume>
                  <issue>3</issue>
                  <fpage>173</fpage>
                  <lpage>177</lpage>
                  <pub-id pub-id-type="doi">10.7126/cumudj.444426</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Meng</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>C-N</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>G-Y</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>H-B</given-names>
                    </name>
                  </person-group>
                  <article-title>Antibacterial and antifungal activities of spices</article-title>
                  <source>Int J Mol Sci</source>
                  <year>2017</year>
                  <volume>18</volume>
                  <issue>6</issue>
                  <fpage>1283</fpage>
                  <pub-id pub-id-type="doi">10.3390/ijms18061283</pub-id>
                  <?supplied-pmid 28621716?>
                  <pub-id pub-id-type="pmid">28621716</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nirmala</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Durai</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Gopakumar</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Nagarajan</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Anticancer and antibacterial effects of a clove bud essential oil-based nanoscale emulsion system</article-title>
                  <source>Int J Nanomed</source>
                  <year>2019</year>
                  <volume>14</volume>
                  <fpage>6439</fpage>
                  <pub-id pub-id-type="doi">10.2147/IJN.S211047</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mostaqim</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Saha</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hani</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Paul</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sharmin</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Basak</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Begum</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Salma</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Shahabuddin</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Antibacterial activities of clove (Syzygium aromaticum) extracts against three food borne pathogens: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa</article-title>
                  <source>Mymensingh Med J: MMJ</source>
                  <year>2019</year>
                  <volume>28</volume>
                  <issue>4</issue>
                  <fpage>779</fpage>
                  <lpage>791</lpage>
                  <?supplied-pmid 31599241?>
                  <pub-id pub-id-type="pmid">31599241</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Purkait</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Bhattacharya</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Bag</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Chattopadhyay</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Synergistic antibacterial, antifungal and antioxidant efficacy of cinnamon and clove essential oils in combination</article-title>
                  <source>Arch Microbiol</source>
                  <year>2020</year>
                  <volume>202</volume>
                  <fpage>1439</fpage>
                  <lpage>1448</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00203-020-01858-3</pub-id>
                  <?supplied-pmid 32185411?>
                  <pub-id pub-id-type="pmid">32185411</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wei</surname>
                      <given-names>H-p</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of different oral care scrubs on ventilator-associated pneumonia prevention for machinery ventilates patient: a protocol for systematic review, evidence mapping, and network meta-analysis</article-title>
                  <source>Medicine</source>
                  <year>2019</year>
                  <volume>98</volume>
                  <issue>12</issue>
                  <fpage>e14923</fpage>
                  <pub-id pub-id-type="doi">10.1097/MD.0000000000014923</pub-id>
                  <?supplied-pmid 30896651?>
                  <pub-id pub-id-type="pmid">30896651</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dale</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Rose</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Carbone</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Pinto</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>OM</given-names>
                    </name>
                    <name>
                      <surname>Burry</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Fan</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Amaral</surname>
                      <given-names>ACK-B</given-names>
                    </name>
                    <name>
                      <surname>McCredie</surname>
                      <given-names>VA</given-names>
                    </name>
                    <name>
                      <surname>Scales</surname>
                      <given-names>DC</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped wedge cluster-randomized controlled trial</article-title>
                  <source>Intensive Care Med</source>
                  <year>2021</year>
                  <volume>47</volume>
                  <issue>11</issue>
                  <fpage>1295</fpage>
                  <lpage>302</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00134-021-06475-2</pub-id>
                  <?supplied-pmid 34609548?>
                  <pub-id pub-id-type="pmid">34609548</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Collins</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Plowright</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Gibson</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Stayt</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Clarke</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Caisley</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Watkins</surname>
                      <given-names>CH</given-names>
                    </name>
                    <name>
                      <surname>Hodges</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Leaver</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Leyland</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>British Association of Critical Care Nurses: evidence-based consensus paper for oral care within adult critical care units</article-title>
                  <source>Nurs Crit Care</source>
                  <year>2021</year>
                  <volume>26</volume>
                  <issue>4</issue>
                  <fpage>224</fpage>
                  <lpage>233</lpage>
                  <pub-id pub-id-type="doi">10.1111/nicc.12570</pub-id>
                  <?supplied-pmid 33124119?>
                  <pub-id pub-id-type="pmid">33124119</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Knaus</surname>
                      <given-names>WA</given-names>
                    </name>
                    <name>
                      <surname>Draper</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Wagner</surname>
                      <given-names>DP</given-names>
                    </name>
                    <name>
                      <surname>Zimmerman</surname>
                      <given-names>JE</given-names>
                    </name>
                  </person-group>
                  <article-title>APACHE II: a severity of disease classification system</article-title>
                  <source>Crit Care Med</source>
                  <year>1985</year>
                  <volume>13</volume>
                  <issue>10</issue>
                  <fpage>818</fpage>
                  <lpage>829</lpage>
                  <pub-id pub-id-type="doi">10.1097/00003246-198510000-00009</pub-id>
                  <?supplied-pmid 3928249?>
                  <pub-id pub-id-type="pmid">3928249</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sutiono</surname>
                      <given-names>AB</given-names>
                    </name>
                    <name>
                      <surname>Arifin</surname>
                      <given-names>MZ</given-names>
                    </name>
                    <name>
                      <surname>Adhipratama</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Hermanto</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>The utilization of APACHE II score to predict the incidence of ventilator-associated pneumonia in patients with severe traumatic brain injury: a single-center study</article-title>
                  <source>Interdiscip Neurosurg</source>
                  <year>2022</year>
                  <volume>28</volume>
                  <fpage>101457</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.inat.2021.101457</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>TavakoliGhuchani</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Sadat Hejazi</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ebrahimi</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Tabei</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Mortality rate of patients admitted to the intensive care unit of Shahid Chamran Hospital of Ferdows City with Acute Physiology and Chronic Health Evaluation (APACHE) II</article-title>
                  <source>J N Khorasan Univ Med Sci</source>
                  <year>2018</year>
                  <volume>10</volume>
                  <issue>1</issue>
                  <fpage>30</fpage>
                  <lpage>35</lpage>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Czajka</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ziębińska</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Marczenko</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Posmyk</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Szczepańska</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Krzych</surname>
                      <given-names>ŁJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Validation of APACHE II, APACHE III and SAPS II scores in in-hospital and one year mortality prediction in a mixed intensive care unit in Poland: a cohort study</article-title>
                  <source>BMC Anesthesiol</source>
                  <year>2020</year>
                  <volume>20</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1186/s12871-020-01203-7</pub-id>
                  <pub-id pub-id-type="pmid">31898488</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ames</surname>
                      <given-names>NJ</given-names>
                    </name>
                    <name>
                      <surname>Sulima</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Yates</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>McCullagh</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Gollins</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Soeken</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Wallen</surname>
                      <given-names>GR</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of systematic oral care in critically ill patients: a multicenter study</article-title>
                  <source>Am J Crit Care</source>
                  <year>2011</year>
                  <volume>20</volume>
                  <issue>5</issue>
                  <fpage>e103</fpage>
                  <lpage>e114</lpage>
                  <pub-id pub-id-type="doi">10.4037/ajcc2011359</pub-id>
                  <?supplied-pmid 21885453?>
                  <pub-id pub-id-type="pmid">21885453</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gupta</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gupta</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Saxsena</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of oral care to prevent VAP in mechanically ventilated intensive care unit patients</article-title>
                  <source>Saudi J Anaesth</source>
                  <year>2016</year>
                  <volume>10</volume>
                  <issue>1</issue>
                  <fpage>95</fpage>
                  <pub-id pub-id-type="doi">10.4103/1658-354X.169484</pub-id>
                  <?supplied-pmid 26955317?>
                  <pub-id pub-id-type="pmid">26955317</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Handa</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Chand</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sarin</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>VA</given-names>
                    </name>
                    <name>
                      <surname>Sharma</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Effectiveness of oral care protocal on oral health status of hospitalised children admitted in Intensive Care Units of selected hospital of Haryana</article-title>
                  <source>Nurs Midwifery Res J</source>
                  <year>2014</year>
                  <volume>10</volume>
                  <issue>1</issue>
                  <fpage>8</fpage>
                  <lpage>15</lpage>
                  <pub-id pub-id-type="doi">10.1177/0974150X20140102</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fartoukh</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Maître</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Honoré</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Cerf</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Zahar</surname>
                      <given-names>J-R</given-names>
                    </name>
                    <name>
                      <surname>Brun-Buisson</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited</article-title>
                  <source>Am J Respir Crit Care Med</source>
                  <year>2003</year>
                  <volume>168</volume>
                  <issue>2</issue>
                  <fpage>173</fpage>
                  <lpage>179</lpage>
                  <pub-id pub-id-type="doi">10.1164/rccm.200212-1449OC</pub-id>
                  <?supplied-pmid 12738607?>
                  <pub-id pub-id-type="pmid">12738607</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pozuelo-Carrascosa</surname>
                      <given-names>DP</given-names>
                    </name>
                    <name>
                      <surname>Herráiz-Adillo</surname>
                      <given-names>Á</given-names>
                    </name>
                    <name>
                      <surname>Alvarez-Bueno</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Añón</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Martínez-Vizcaíno</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Cavero-Redondo</surname>
                      <given-names>I</given-names>
                    </name>
                  </person-group>
                  <article-title>Subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis</article-title>
                  <source>Eur Respir Rev</source>
                  <year>2020</year>
                  <volume>29</volume>
                  <issue>151</issue>
                  <fpage>190107</fpage>
                  <pub-id pub-id-type="doi">10.1183/16000617.0107-2019</pub-id>
                  <?supplied-pmid 32051169?>
                  <pub-id pub-id-type="pmid">32051169</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <mixed-citation publication-type="other">Amrithaa B, Cecil A, Rajeshkumar S (2022) Comparative antimicrobial activity of chamomile and clove based mouthwash with commercial mouthwash. Int J Early Child Spec Educ (INT-JECSE) 14:5445–5450. 10.9756/INT-JECSE/V14I2.609</mixed-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gupta</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Prakash</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparative study of the antimicrobial activity of clove oil and clove extract on oral pathogens</article-title>
                  <source>Dent - Open J</source>
                  <year>2021</year>
                  <volume>6</volume>
                  <issue>1</issue>
                  <fpage>12</fpage>
                  <lpage>15</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.carbpol.2020.117339</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>NM</given-names>
                    </name>
                    <name>
                      <surname>Tariq</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Naim</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Antimicrobial activities of Clove Buds and Miswak againts Viridans group Streptococci</article-title>
                  <source>INT J BIOL BIOTECH</source>
                  <year>2021</year>
                  <volume>18</volume>
                  <issue>2</issue>
                  <fpage>247</fpage>
                  <lpage>252</lpage>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sahu</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sahoo</surname>
                      <given-names>AK</given-names>
                    </name>
                    <name>
                      <surname>Swain</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Bhattacharyay</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>In silico analysis of phytochemicals from clove against bronchitis</article-title>
                  <source>Eur J Med Plants</source>
                  <year>2020</year>
                  <volume>20</volume>
                  <fpage>34</fpage>
                  <lpage>39</lpage>
                  <pub-id pub-id-type="doi">10.9734/EJMP/2020/v31i530239</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <mixed-citation publication-type="other">Green A (n.d.) Anti-respiratory syncytial virus activity of clove extract,University of Gothenburg / Institute of Medicine. Sahlgrenska AcademyInstitute of biomedicine 2020: 1–31</mixed-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Faujdar</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Bisht</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Sharma</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Antibacterial activity of Syzygium aromaticum (clove) against uropathogens producing ESBL, MBL, and AmpC beta-lactamase: are we close to getting a new antibacterial agent?</article-title>
                  <source>J Fam Med Prim Care</source>
                  <year>2020</year>
                  <volume>9</volume>
                  <issue>1</issue>
                  <fpage>180</fpage>
                  <pub-id pub-id-type="doi">10.4103/jfmpc.jfmpc_908_19</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wongsawan</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Chaisri</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Tangtrongsup</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Mektrirat</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Bactericidal effect of clove oil against multidrug-resistant Streptococcus suis isolated from human patients and slaughtered pigs</article-title>
                  <source>Pathogens</source>
                  <year>2020</year>
                  <volume>9</volume>
                  <issue>1</issue>
                  <fpage>14</fpage>
                  <pub-id pub-id-type="doi">10.3390/pathogens9010014</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yassin</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Mostafa</surname>
                      <given-names>AA-F</given-names>
                    </name>
                    <name>
                      <surname>Al-Askar</surname>
                      <given-names>AA</given-names>
                    </name>
                  </person-group>
                  <article-title>In vitro anticandidal potency of Syzygium aromaticum (clove) extracts against vaginal candidiasis</article-title>
                  <source>BMC Complement Med Ther</source>
                  <year>2020</year>
                  <volume>20</volume>
                  <issue>1</issue>
                  <fpage>25</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12906-020-2818-8</pub-id>
                  <?supplied-pmid 32020877?>
                  <pub-id pub-id-type="pmid">32020877</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mahajan</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Khinda</surname>
                      <given-names>PK</given-names>
                    </name>
                    <name>
                      <surname>Gill</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Kaur</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Saravanan</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sahewal</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Taneja</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Joshi</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of efficacy of 0.2% chlorhexidine gluconate and herbal mouthrinses on dental plaque: an in vitro comparative study</article-title>
                  <source>Eur J Med Plants</source>
                  <year>2016</year>
                  <volume>13</volume>
                  <issue>2</issue>
                  <fpage>1</fpage>
                  <pub-id pub-id-type="doi">10.9734/EJMP/2016/23318</pub-id>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bansal</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Gupta</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bhaduri</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Shaikh</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Sayed</surname>
                      <given-names>FR</given-names>
                    </name>
                    <name>
                      <surname>Bansal</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Agrawal</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Assessment of antimicrobial effectiveness of neem and clove extract against Streptococcus mutans and Candida albicans: an in vitro study</article-title>
                  <source>Niger Med J: J Niger Med Assoc</source>
                  <year>2019</year>
                  <volume>60</volume>
                  <issue>6</issue>
                  <fpage>285</fpage>
                  <pub-id pub-id-type="doi">10.4103/nmj.NMJ_20_19</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pacheco-Fowler</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Gaonkar</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Wyer</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Modak</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Antiseptic impregnated endotracheal tubes for the prevention of bacterial colonization</article-title>
                  <source>J Hosp Infect</source>
                  <year>2004</year>
                  <volume>57</volume>
                  <issue>2</issue>
                  <fpage>170</fpage>
                  <lpage>174</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jhin.2004.03.011</pub-id>
                  <?supplied-pmid 15183249?>
                  <pub-id pub-id-type="pmid">15183249</pub-id>
                </element-citation>
              </ref>
              <ref id="CR63">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van Nieuwenhoven</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Vandenbroucke-Grauls</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>van Tiel</surname>
                      <given-names>FH</given-names>
                    </name>
                    <name>
                      <surname>Joore</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>van Schijndel</surname>
                      <given-names>RJS</given-names>
                    </name>
                    <name>
                      <surname>van der Tweel</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Ramsay</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Bonten</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study</article-title>
                  <source>Crit Care Med</source>
                  <year>2006</year>
                  <volume>34</volume>
                  <issue>2</issue>
                  <fpage>396</fpage>
                  <lpage>402</lpage>
                  <pub-id pub-id-type="doi">10.1097/01.ccm.0000198529.76602.5e</pub-id>
                  <?supplied-pmid 16424720?>
                  <pub-id pub-id-type="pmid">16424720</pub-id>
                </element-citation>
              </ref>
              <ref id="CR64">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Younes</surname>
                      <given-names>SAR</given-names>
                    </name>
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>NT</given-names>
                    </name>
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>IM</given-names>
                    </name>
                    <name>
                      <surname>Hassan</surname>
                      <given-names>EA</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of multimodality chest physiotherapy interventions on prevention of ventilator associated pneumonia among mechanically ventilated patients</article-title>
                  <source>Alex Sci Nurs J</source>
                  <year>2022</year>
                  <volume>24</volume>
                  <issue>1</issue>
                  <fpage>36</fpage>
                  <lpage>46</lpage>
                </element-citation>
              </ref>
              <ref id="CR65">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Erinc</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kutbay Ozcelik</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Yigitbas</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Yurt</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Kosar</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Does subglottic secretion drainage prevent ventilator-associated pneumonia?</article-title>
                  <source>Eurasian J Pulmonol</source>
                  <year>2018</year>
                  <volume>20</volume>
                  <issue>3</issue>
                  <fpage>122</fpage>
                  <pub-id pub-id-type="doi">10.4103/ejop.ejop</pub-id>
                </element-citation>
              </ref>
              <ref id="CR66">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Luyt</surname>
                      <given-names>C-E</given-names>
                    </name>
                    <name>
                      <surname>Hékimian</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Koulenti</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Chastre</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia</article-title>
                  <source>Curr Opin Crit Care</source>
                  <year>2018</year>
                  <volume>24</volume>
                  <issue>5</issue>
                  <fpage>332</fpage>
                  <lpage>338</lpage>
                  <pub-id pub-id-type="doi">10.1097/MCC.0000000000000526</pub-id>
                  <?supplied-pmid 30036192?>
                  <pub-id pub-id-type="pmid">30036192</pub-id>
                </element-citation>
              </ref>
              <ref id="CR67">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Malicka</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Skośkiewicz-Malinowska</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Kaczmarek</surname>
                      <given-names>U</given-names>
                    </name>
                  </person-group>
                  <article-title>The impact of socioeconomic status, general health and oral health on Health-Related Quality of Life, Oral Health-Related Quality of Life and mental health among Polish older adults</article-title>
                  <source>BMC Geriatr</source>
                  <year>2022</year>
                  <volume>22</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>15</lpage>
                  <pub-id pub-id-type="doi">10.1186/s12877-021-02716-7</pub-id>
                  <pub-id pub-id-type="pmid">34979941</pub-id>
                </element-citation>
              </ref>
              <ref id="CR68">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Terezakis</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Needleman</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Kumar</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Moles</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Agudo</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>The impact of hospitalization on oral health: a systematic review</article-title>
                  <source>J Clin Periodontol</source>
                  <year>2011</year>
                  <volume>38</volume>
                  <issue>7</issue>
                  <fpage>628</fpage>
                  <lpage>636</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1600-051X.2011.01727.x</pub-id>
                  <?supplied-pmid 21470276?>
                  <pub-id pub-id-type="pmid">21470276</pub-id>
                </element-citation>
              </ref>
              <ref id="CR69">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Luyt</surname>
                      <given-names>C-E</given-names>
                    </name>
                    <name>
                      <surname>Sahnoun</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Gautier</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Vidal</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Burrel</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Pineton de Chambrun</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Chommeloux</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Desnos</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Arzoine</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Nieszkowska</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study</article-title>
                  <source>Ann Intensive Care</source>
                  <year>2020</year>
                  <volume>10</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="doi">10.1186/s13613-020-00775-4</pub-id>
                  <pub-id pub-id-type="pmid">31900667</pub-id>
                </element-citation>
              </ref>
              <ref id="CR70">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bao</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Dong</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral microbiome and SARS-CoV-2: beware of lung co-infection</article-title>
                  <source>Front Microbiol</source>
                  <year>2020</year>
                  <volume>11</volume>
                  <fpage>1840</fpage>
                  <pub-id pub-id-type="doi">10.3389/fmicb.2020.01840</pub-id>
                  <?supplied-pmid 32849438?>
                  <pub-id pub-id-type="pmid">32849438</pub-id>
                </element-citation>
              </ref>
              <ref id="CR71">
                <label>71.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khaky</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Yazdannik</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mahjobipoor</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluating the efficacy of nanosil mouthwash on the preventing pulmonary infection in intensive care unit: a randomized clinical trial</article-title>
                  <source>Med Arch</source>
                  <year>2018</year>
                  <volume>72</volume>
                  <issue>3</issue>
                  <fpage>206</fpage>
                  <pub-id pub-id-type="doi">10.5455/medarh.2018.72.206-209</pub-id>
                  <?supplied-pmid 30061768?>
                  <pub-id pub-id-type="pmid">30061768</pub-id>
                </element-citation>
              </ref>
              <ref id="CR72">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Babaii</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Abbasinia</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bahrami</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>The effect of artificial airway standardization cares on the ventilator-associated pneumonia</article-title>
                  <source>J Urmia Nurs Midwifery Fac</source>
                  <year>2016</year>
                  <volume>13</volume>
                  <issue>11</issue>
                  <fpage>987</fpage>
                  <lpage>994</lpage>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
